U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460947) titled 'A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder' on Feb. 05.

Brief Summary: This study tests a new treatment for people with borderline personality disorder (BPD). The treatment combines a medication called D-cycloserine with one day of transcranial magnetic stimulation (TMS).

The main questions it aims to answer are:

* How many participants complete the treatment?

* How do participants feel about the treatment?

* Does the treatment have neurophysiological changes on participants?

* Does the treatment improve BPD symptoms?

* Do the benefits last over time? ...